Clorox (CLX) put its dividend policy back in focus after the board declared a quarterly payout of $1.25 per share, payable on February 12, 2027, to shareholders of record as of January 27.
Despite the dividend news, Clorox’s share price has been choppy, with a 1-day share price return that declined 3.22% and a 7-day share price return that fell 3.05%. However, the 30-day share price return gained 19.95%, and year to date it is up 4.02%.
Scan how Clorox’s dividend move compares by sizing up other income-focused opportunities in our curated list of 8 dividend fortresses.
Clorox still looks like a solid everyday essentials franchise, yet the stock just rose almost 20% over 30 days after a wobbly few years. Is that renewed optimism already reflected in the price, or not yet?
Clorox last closed at $104.90, while the analyst consensus Narrative on Simply Wall St points to a fair value of $97.47 using a 7.24% discount rate. That gap frames a view that the recent share price swing already builds in a lot of the recovery story.
The full-scale implementation of a modern ERP system is now moving from stabilization into optimization. Clorox has indicated that late FY27 and FY28 should see better demand fulfillment, lower inventories and more automation in order-to-cash and back-office functions, which would primarily support net margin and earnings.
See why 49 investors see Clorox as 8% overvalued.
Result: Fair Value of $97.47 (OVERVALUED)
Still, the Clorox story can break the other way if input and logistics costs stay elevated, or if value seeking shoppers keep pressuring volumes and pricing power.
Find out about the key risks to this Clorox narrative.
On simple multiples, Clorox looks less stretched than that 8% overvalued fair value line suggests. The stock trades on a P/E of 18.8x, compared with 25.9x for peer companies and 17.4x for the broader Global Household Products group, while the fair ratio sits at 19.7x. That cluster of numbers points to only a modest valuation gap rather than a clear bubble. This raises a practical question for investors: Is this really pricing in too much hope, or just asking a small premium for a long-lived household franchise?
For a closer look at how this earnings multiple stacks up against the fair ratio and sector, including what that could mean for upside or downside risk, See what the numbers say about this price — find out in our valuation breakdown.
Mixed signals around Clorox can feel confusing, so move quickly to test the numbers, weigh sentiment, and decide where you stand with 2 key rewards and 2 important warning signs
Do not stop your research at Clorox alone. Use the Simply Wall St screener to pressure test your next moves and avoid leaving promising ideas on the table.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com